Facebook
Instagram
Pinterest
Reddit
Tumblr
X
Youtube
Home
About
News
Events
Shop
Directory
Contact Us
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
PsyNews.com
Home
About
News
Events
Shop
Directory
Contact Us
Home
Featured
Page 175
Featured
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Quarterly Psychedelics Briefing: Q3 2026
Weekly Psychedelic Policy Briefing, September 21, 2026
Health Canada Authorizes Optimi’s Natural Psilocybin Trial as House Bill Targets Botanical Drug Exclusivity
Pα+ Psychedelic Bulletin #232: Q2’26 Psychedelic Lobbying Update; DEA Again Moves to Schedule 5 Tryptamines; Oregon Backpedals Psilocybin Fee Hike
Podcast: Psychedelics in D.C., FDA’s Framework, and New Zealand’s MDMA Prescribers
Issues of Patient Safety and Ethical Violations in Psychedelic Therapy
Psychedelic Bulletin #115 – Mydecine Looks Set to Shutter; MindMed Gains...
PT348 – Steve DeAngelo – Cannabis and Psychedelics: Industry, Consciousness, Justice,...
HAVN Life Announces the close of the first tranche of its...
Bright Minds Biosciences Comments on Recent Trading Activity
Small Pharma Announces TSXV Approval of Normal Course Issuer Bid
FILAMENT HEALTH ANNOUNCES EIGHTH PATENT ISSUANCE
Reunion Neuroscience Inc. to Commence Trading on the Toronto Stock Exchange...
PT347 – Christopher Koddermann – Rescheduling Psilocybin, Patents and IP, and...
Health Canada Grants MDMA Production and Distribution Amendment to Optimi Health
Load more